slotkoers
Korea S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
16.900
KRW
|
-0,65%
|
|
+2,36%
|
-13,73%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
1.060.049
|
754.291
|
1.053.608
|
1.122.398
|
731.488
|
1.103.200
|
Bedrijfswaarde
1 |
930.343
|
679.221
|
1.008.402
|
1.120.060
|
956.547
|
1.331.046
|
K/w-verhouding
|
83,8
x
|
17,7
x
|
-56,3
x
|
-77,8
x
|
-15,4
x
|
-112
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,17
x
|
1,41
x
|
1,59
x
|
1,54
x
|
0,87
x
|
1,16
x
|
Bedrijfswaarde/omzet
|
1,9
x
|
1,27
x
|
1,52
x
|
1,54
x
|
1,13
x
|
1,4
x
|
Bedrijfswaarde/EBITDA
|
28,2
x
|
25,4
x
|
50,6
x
|
32,7
x
|
-45,2
x
|
46,9
x
|
Bedrijfswaarde/FCF
|
-10,4
x
|
-6,33
x
|
-13,2
x
|
-95,1
x
|
-6,24
x
|
-7,41
x
|
FCF Yield
|
-9,63%
|
-15,8%
|
-7,56%
|
-1,05%
|
-16%
|
-13,5%
|
Price to Book
|
3,24
x
|
2
x
|
2,97
x
|
2,46
x
|
2,51
x
|
3,92
x
|
Aantal aandelen (in duizenden)
|
52.478
|
52.200
|
52.549
|
56.261
|
56.268
|
56.314
|
Referentieprijs
2 |
20.200
|
14.450
|
20.050
|
19.950
|
13.000
|
19.590
|
Datum van publicatie
|
08-04-19
|
18-03-20
|
18-03-21
|
18-03-22
|
22-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
488.600
|
534.612
|
664.717
|
727.476
|
844.583
|
953.951
|
EBITDA
1 |
32.980
|
26.764
|
19.924
|
34.260
|
-21.149
|
28.374
|
Bedrijfsresultaat (EBIT)
1 |
18.079
|
4.350
|
-5.517
|
6.397
|
-53.669
|
-9.425
|
Operationele Marge
|
3,7%
|
0,81%
|
-0,83%
|
0,88%
|
-6,35%
|
-0,99%
|
Resultaat voor belastingen (EBT)
1 |
36.590
|
67.310
|
-30.981
|
-10.033
|
-71.302
|
3.188
|
Nettowinst (verlies)
1 |
24.389
|
46.375
|
-18.658
|
-13.968
|
-47.543
|
-8.431
|
Nettomarge
|
4,99%
|
8,67%
|
-2,81%
|
-1,92%
|
-5,63%
|
-0,88%
|
WPA
2 |
241,1
|
817,4
|
-356,0
|
-256,3
|
-845,0
|
-175,4
|
Free Cash Flow
1 |
-89.608
|
-107.245
|
-76.244
|
-11.777
|
-153.209
|
-179.722
|
FCF-marge
|
-18,34%
|
-20,06%
|
-11,47%
|
-1,62%
|
-18,14%
|
-18,84%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
08-04-19
|
18-03-20
|
18-03-21
|
18-03-22
|
22-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
225.058
|
227.846
|
Nettokaspositie
1 |
129.706
|
75.070
|
45.206
|
2.337
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-10,64
x
|
8,03
x
|
Free Cash Flow
1 |
-89.608
|
-107.245
|
-76.244
|
-11.777
|
-153.209
|
-179.722
|
ROE (netto-inkomsten/eigen vermogen)
|
7,59%
|
8,61%
|
-5,25%
|
-3,06%
|
-9,64%
|
-0,85%
|
ROA (netto-inkomsten/totale activa)
|
1,3%
|
0,26%
|
-0,28%
|
0,28%
|
-2,14%
|
-0,35%
|
Totale activa
1 |
1.879.278
|
18.002.563
|
6.701.936
|
-4.978.074
|
2.226.828
|
2.385.077
|
Nettoactief per aandeel
2 |
6.231
|
7.226
|
6.757
|
8.106
|
5.185
|
4.996
|
Cashflow per aandeel
2 |
1.706
|
2.248
|
2.306
|
2.178
|
1.184
|
1.078
|
Capex
1 |
78.140
|
107.773
|
126.227
|
112.598
|
120.355
|
70.365
|
Capex/omzet
|
15,99%
|
20,16%
|
18,99%
|
15,48%
|
14,25%
|
7,38%
|
Datum van publicatie
|
08-04-19
|
18-03-20
|
18-03-21
|
18-03-22
|
22-03-23
|
20-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -13,73% | 691 mln. | | +1,51% | 42,75 mld. | | +8,57% | 41,34 mld. | | +49,22% | 41,61 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | +29,17% | 12,24 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|